CLL Coverage from Every Angle

Jennifer A. Woyach, MD, on Using MRD to Treat CLL/SLL

Posted: Monday, November 22, 2021

Jennifer A. Woyach, MD, of The Ohio State University Comprehensive Cancer Center, discusses the logistical challenges for practitioners when it comes to assessing minimal residual disease in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma and determining the best course of treatment.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.